DuPont Nutrition & Health, Madison, WI, has attained official confirmation from the U.S. Food & Drug Administration (FDA) that the probiotic strains in its Bifidobacterium lactis range are recognized as safe and suitable for use in all food products and dietary supplements. FDA had previously granted the Bifidobacterium lactic strains full GRAS status for use in dairy applications. With this notification, FDA extends the status to food categories such as juice, dry beverages, confectionery and bakery products and the dietary supplement market, where probiotics are widely used. DuPont previously had self-affirmed GRAS status for the use of its Bifidobacterium lactis strains in this range of additional applications.
Strains in the B. lactis range include Bifidobacterium lactis HN019, marketed as HOWARU Bifido. DuPont also produces Bifidobacterium lactis Bi-07 and Bifidobacterium lactis Bl-04, part of the FloraFIT custom probiotics range for dietary supplements and nutritionals.